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INTRODUCTION
It is known that hypoxic condition is one of the most 
common causes of cell death and damage. This is due 
to the presence of conservative mechanisms of the 
regulation of oxygen homeostasis and homeostasis. 
One of these systems, associated with a cascade of 
hypoxia-inducible factor, leads to the synthesis of 
erythropoietin (EPO), which is a glycoprotein with 
a molecular weight of the order of 30.4 kDa.[1,2] 
This molecule is best known as a positive regulator 
of erythropoiesis, which is mainly produced in the 
kidneys in response to a decrease in the partial pressure 
of oxygen. However, the spectrum of the physiological 
effects of EPO is quite wide and allows us to consider it 
as an agent with a universal cytoprotective directivity. 
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The cascades initiated by them lead to an increase 
in the resistance of cells to damage, which has been 
proven on models of ischemia in almost all organs.[3-5] 
With ischemic lesions of different organs, EPO causes 
angiogenic, antioxidant, anti-inflammatory, and 
antiapoptotic effects,[6,7] which leads to a reduction 
in the area of damage.[8] The implementation of the 
cellular effects of EPO occurs when it binds to two 
receptors (EPO receptor – [R]), resulting in the 
formation of a homodimer. The latter leads to the 
activation of many intracellular factors, among which 
the main role in cytoprotection is removed by Akt, 
which inactivates caspases, resulting in damage to 
mitochondria, disruption of cellular homeostasis, and 
initiation of apoptosis.[9] At the same time, due to the 
activation of a large number of secondary mediators, 
EPO is able to cause the development of such negative 
effects as an increase in endothelin production, an 
increase in tissue renin concentration, a change in 
the balance of prostaglandins in the vascular tissue, 
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stimulation of angiogenesis, and proliferation of 
smooth muscle cells.[10,11] Carbamylated darbepoetin 
is fundamentally different from drugs based on EPO, 
combining the best qualities of the drugs of previous 
generations.[12,13]
Aim
The aim was the study of the cerebroprotective effect 
of carbamylated darbepoetin in a four-vessel model of 
rat brain ischemia-reperfusion.
MATERIALS AND METHODS
The material of the study was 40 rats of the Wistar 
line, which were divided into four groups. The first 
group consisted of 10 intact animals, the second 
group included 10 pseudo-operated animals, and 
Groups 3 and 4 consisted of 10 rats with a 4-min four-
vascular model of cerebral ischemia without prior 
administration of darbepoetin and its administration, 
respectively. When modeling a four-vessel model of 
cerebral ischemia in the field of the operating field, 
the scalp was removed with the help of a depilation 
cream followed by treatment with an antiseptic. Then, 
a small incision of soft tissues was made along the 
middle line of the neck and the muscles were moved 
apart by blunt dissection. The right and left common 
carotid arteries were isolated. The tracheal tube, the 
thyroid gland, was pushed aside to open the access to 
the vertebral column. Coagulation of vertebral arteries 
was carried out at the level of C2-C3 segments of 
the spinal cord. Then, overlapping the lumen of the 
carotid arteries, the electroencephalography (EEG) 
was recorded. This was the main criterion for an 
adequately implemented methodology. Blood flow in 
the pool of carotid arteries was restored after 4 min, 
after which the wound was layer-by-layer sutured; the 
operating field was treated with an antiseptic solution. 
EEG was performed using an EEG MP150 EEG100C. 
The neurological deficit is a consequence of cerebral 
ischemia and is accompanied by a change in the 
standard neurological status (paresis, plegia, impaired 
sensitivity, dizziness, etc.).[14]
To assess the neurological status of rats, the following 
methods were used:
1. A grading school of McGraw’s stroke assessment 
in the modification of IV Gannushkina.[14] Within 
the group of rats with signs of neurologic deficiency 
was divided into animals with mild, moderate, and 
severe symptoms of neurologic deficiency. If the 
animal had several signs of a neurological deficit, 
the points were summed up.
2. Infrared activity monitor: “Infrared activity 
monitor” includes a two-dimensional square frame 
and an infrared ray system for detecting movements 
of an animal. IR Actimeter allows you to perform 
testing of voluntary motor activity, the number and 
duration of hitching episodes, stereotyped motions, 
and research behavior in the “perforated field” 
model under daylight and nighttime conditions. 
ActiTrack software allows you to analyze the 
trajectory of an animal’s movement (distance, 
speed, and time spent in certain zones). To assess 
the orienting-research behavior, the installation of 
Panlab Harvard Apparatus LE 8825 was used.
The animals were withdrawn from the experiment 
24 and 72 h after the start of the study. For the 
morphological study, the brain was taken; it was 
fixed in 10% neutral buffered formalin for 24–48 h. 
Thereafter, the preparation was subjected to standard 
wiring on a Leica TP 1020 apparatus, poured into 
paraffin, slices 4–5 μm thick, and stained with 
hematoxylin and eosin and toluidine blue in Nissl’s 
modification using standard protocols and procedures 
on Leica EG 1150 H, Leica RM 2245, and Leica 
Autostainer XL.
Immunohistochemical reactions were performed 
with glial fibrillary acidic protein (GFAP) antibodies 
(clone EP672Y, CellMarque), NSE (clone MRQ55, 
CellMarque), p53 (clone DO7, CellMarque), and Ki 
67 (clone NE14, Biogenex). The streptavidin-biotin 
method (LSAB Kit) was used, as diaminobenzidine 
as the chromogen. Unmask antigens were made 
by heating in citrate buffer (pH 6.0) for 40 min at a 
temperature of 93–95°C. The immunohistochemical 
study was performed in the immunohistochemistry 
department of the Belgorod Regional Pathoanatomical 
Bureau (TS Mukhina). The photoprotocols were 
performed on the MiraxDesk scanner (Carl Zeiss 
Microimaging GMbH, Germany), the Nikon Eclipse 
Ni microscope with the Nis-Elements BR 4.60.00 
software. Statistical calculations were carried out with 
the help of Statistica 10.0.
Experimental
At the beginning of the experiment, all animals were 
randomized according to the degree of resistance to 
hypoxia. In the study, animals with average stability 
indicators participated. Animals in the fourth group 
were intraperitoneally injected with carbamylated 
darbepoetin at a dose of 100 mcg/kg at an interval of 
3 days. To achieve the goal, a four-vessel model of total 
cerebral ischemia was used. Rats were anesthetized 
with Zoletil at a dose of 60 mg/kg and chloral 
hydrate intraperitoneally at a dose of 150 mg kg, 
after which surgery was performed. The criterion for 
an adequately performed procedure was the level of 
decrease in EEG amplitude [Figure 1]. The episode of 
ischemia was 4 min. After removal of the clip from the 
common carotid arteries and suturing of the operating 
wound, restoration of the blood flow of the brain was 
confirmed with a repeated EEG [Figure 2], and then, 
neurological disorders were recorded. The animals 
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were withdrawn from the experiment 24 and 72 h later 
with a morphological study of the brain. In groups 
of intact and pseudo-operated animals, carbamylated 
darbepoetin was not administered, as well as in the 
third group with 4-min total ischemia.
In the first and second groups, neurologic symptoms 
were absent. In the histological examination of 
the brain, there were no specific features in the 
structure of the neurons of the CA1-CA3 regions of 
the hippocampus, gyrus dentatus, frontal cortex, and 
parietal lobe.
In rats in the third group, after 4-min total ischemia, 
massive neurologic disorders were observed, which 
almost completely disappeared by the end of the 
1st day. They were manifested by paresis, paralysis, 
lethargy, and slowing movements. By the end of the 3rd 
day, the symptoms of the nervous system were absent.
When examining by the microscope, the brain of rats of 
the third group, massive perivascular and pericellular 
edema, fullness of small vessels and capillaries of brain 
substance, as well as vascular plexuses were detected. 
In the dentate gyrus neurons, in the regions of the 
CA1-CA3 hippocampus, pronounced degenerative 
changes of the majority of neurons characterized 
by subtotal disorganization of their layers, partial 
cellular depopulation are revealed [Figures 3 and 4]. 
Changes in the nuclei of neurons were recorded 
in the form of swelling, fuzziness of contours, 
karyopyknosis, and karyorrhexis. Polymorphic changes 
of the chromatophilic substance in the form of focal 
chromatography, lumpy condensation, and fuzziness 
of the structure of the apical dendrites of pyramidal 
neurons of the cerebral cortex were also revealed 
[Figure 5]. These changes were clearly visible both in 
the staining of hematoxylin and eosin and in the use of 
toluidine blue according to the Nissl method.[15-17] In one 
case, the paraventricular gliosis focus was recorded.
In immunohistochemical studies in animals of the third 
group in areas of the brain with the greatest sensitivity 
to hypoxia and massive changes in the visual color, 
there was a lack of expression with antibodies to NSE 
and p53. In this case, the reaction with antibodies to 
GFAP is positive, with a slight decrease in the number 
of glial cells and their processes [Figures 5 and 6].
In the fourth group of animals, the pronounced 
neuroprotective effect of carbamylated darbepoetin 
was revealed, which was manifested by the 
preservation of the neuronal layers of the hippocampus 
and the cerebral cortex, the presence of single 
Figure 1: Electroencephalogram before total ischemia (a), during ischemia (b), and after ischemia (c)
Figure 2: Electroencephalogram during reperfusion of the brain (after total ischemia; the arrow point time of stating)
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neurons with obvious signs of ischemic damage and 
degeneration. However, these changes were observed 
against a background of perivascular and pericellular 
edema expressed by the embolism of small vessels 
and capillaries of the brain substance and its vascular 
plexuses [Figures 3b and 4b].
CONCLUSION
1. A four-vessel model of total cerebral ischemia is 
technically complex but an adequate technique for 
investigating ischemic brain damage.
2. Carbamylated darbepoetin has an evident 
neuroprotective effect.
3. The preconditioning effect of carbamylated darbepoetin 
on the microcirculatory bed is not revealed.
4. Negative immunohistochemical reaction with 
NSE, GFAP, and p53 was identified in brain areas 
with ischemic lesions such as CA1-CA3 fields of 
hippocampus.
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Figure 3: Neuronal degeneration of CA1 area of the 
hippocampus without carbamylated darbepoetin (a) and 
after its administration (b) hematoxylin and eosin. a, b × 400
a b
Figure 4: Neuronal degeneration of cerebral cortex without 
carbamylated darbepoetin (a) and after its administration 
(b) hematoxylin and eosin. a, b × 400
a b
Figure 5: Neuronal degeneration of CA1 area of the 
hippocampus without carbamylated darbepoetin (a) and 
negative reaction with NSE antibodies (b) Nissl reaction 
(a) and IHC reaction with NSE antibodies. a, b × 400
a b
Figure 6: Glial fibrillary acidic protein-positive reaction in 
the third group (a) and p53 negative reaction (b) × 400
ba
